RU2589707C1 - Method for correction of epicanthus - Google Patents

Abstract

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to cosmetic medicine and ophthalmology, and concerns the correction of epicanthus. This is provided by injection of gel stabilised hyaluronic acid of non-animal origin with density 22 mg/ml. Gel is introduced in the volume of 0.2 ml supraperiostally in area of joint between right and left nasal bones.

EFFECT: method provides effective correction of epicanthus without surgical intervention and related side effects.

1 cl, 1 ex

Description

The invention relates to ophthalmology and can be used to correct epicanthus in order to eliminate cosmetic deficiency.

Epicanthus is found mainly in patients with an eastern section of the eye, less often in individuals of the Europioid race. The overhanging skin fold above the inner corner of the eye, which is usually directed downward and medially, is regarded by patients as a cosmetic defect requiring correction. Despite numerous developments, the problem of epicanthus correction remains relevant at present. According to some authors, the frequency of occurrence of epicanthal folds in the Asian population ranges from 40% to 90%, in other racial groups from 2% to 5% (Park J.I., 2000).

A known method for the correction of epicanthus by performing in the region of the inner corner of the eye a Y-shaped skin incision in the horizontal direction with a length of each shoulder of the incision 4-5 mm. In this case, the medial shoulder of the incision is directed from the medial adhesion horizontally to the nose. Symmetrical diverging shoulders are positioned along the edges of the inner corner 2-3 mm from the edges. Their ends are directed to the edges of the eyelids to the level of their front ribs, not reaching the lacrimal openings. Separate skin flaps. The middle flap is moved medially and fixed. The lateral flaps are adapted accordingly to the adjacent edges of the incision (patent RU 2217114, 2002)

However, the disadvantage of the proposed method is the complexity and invasiveness due to the possibility of the development of rough scarring in the area of surgical intervention.

There is a method of eliminating the epicanthus, which consists in making a linear incision of the skin above the corner of the eye and medial of the epicanthal fold, subcutaneously excising a section of the connective tissue cord forming the epicanthus, and the incision is sutured with fixation of the skin to the medial ligament, periosteum, tarsoorbital fascia and levator aponeurosis upper eyelid (patent RU 2179424, 2002).

However, the claimed method is time-consuming and traumatic, since as a result of surgical intervention, deforming scars are formed.

When conducting an information search, no methods for non-surgical correction of epicanthus were found.

The technical result of the proposed method is to reduce the morbidity and increase the cosmetic effect in the correction of epicanthus.

The technical result is achieved in that under local application anesthesia, a gel of stabilized hyaluronic acid of non-animal origin is injected with a density of 22 mg / ml in a volume of 0.2 ml supraperiostally into the junction of the right and left nasal bones.

The author proposes a method for the correction of epicanthus, which allows for minimal cosmetic results to achieve good cosmetic results without the formation of scar tissue.

The method is as follows

A gel of stabilized hyaluronic acid of non-animal origin with a density of 22 mg / ml (for example, YVOIRE volume, manufactured by LG Life Sciences, South Korea) is injected under local application anesthesia in a volume of 0.2 ml supraperiostally into the junction of the right and left nasal bones, resulting in more high nasal bridge, which contributes to a change in the vector of tissue tension in the nose and reduces the severity of the epicanthus.

The claimed method performed the correction of epicanthus to 3 patients aged 25 to 38 years of Europioid race. After the procedure, all patients had moderate hyperemia in the nose, which took place 15-20 minutes after the procedure. During epicanthus correction, a good cosmetic effect was achieved, which lasted from 6 to 8 months.

Example.

Patient A., 25 years old, ambulatory card N 1065, diagnosis - bilateral epicanthus. Under local application anesthesia, an injection of a stabilized hyaluronic acid gel of non-animal origin with a density of 22 mg / ml in a volume of 0.2 ml supraperiostally was injected with a 27G needle into a joint of the right and left nasal bones with a 27G needle. Within 15 minutes after the procedure, moderate hyperemia was observed in the injection area. Formed a higher nasal bridge in this area. There is a good cosmetic effect.

Thus, the claimed method of correction of epicanthus allows without surgical intervention to obtain a good cosmetic result and will be widely used in ophthalmology and cosmetology.

Claims (1)

A method for correcting epicanthus is that under local application anesthesia a gel of stabilized non-animal hyaluronic acid is injected with a density of 22 mg / ml in a volume of 0.2 ml supraperiostally into the junction of the right and left nasal bones.